NewEdge Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $336K | Buy |
2,673
+316
| +13% | +$39.7K | ﹤0.01% | 1950 |
|
2025
Q1 | $323K | Sell |
2,357
-22
| -0.9% | -$3.01K | ﹤0.01% | 1848 |
|
2024
Q4 | $364K | Sell |
2,379
-22
| -0.9% | -$3.36K | ﹤0.01% | 1762 |
|
2024
Q3 | $465K | Sell |
2,401
-612
| -20% | -$119K | ﹤0.01% | 1518 |
|
2024
Q2 | $699K | Sell |
3,013
-358
| -11% | -$83K | 0.01% | 1231 |
|
2024
Q1 | $727K | Sell |
3,371
-3,168
| -48% | -$683K | 0.01% | 1155 |
|
2023
Q4 | $1.65M | Buy |
6,539
+3,172
| +94% | +$801K | 0.02% | 735 |
|
2023
Q3 | $865K | Buy |
3,367
+314
| +10% | +$80.7K | 0.01% | 925 |
|
2023
Q2 | $870K | Buy |
3,053
+745
| +32% | +$212K | 0.01% | 935 |
|
2023
Q1 | $642K | Sell |
2,308
-559
| -19% | -$155K | 0.01% | 1000 |
|
2022
Q4 | $759K | Buy |
2,867
+1,768
| +161% | +$468K | 0.02% | 611 |
|
2022
Q3 | $293K | Sell |
1,099
-6,359
| -85% | -$1.7M | ﹤0.01% | 1217 |
|
2022
Q2 | $1.52M | Buy |
+7,458
| New | +$1.52M | 0.03% | 513 |
|
2021
Q4 | – | Sell |
-1,205
| Closed | -$341K | – | 1639 |
|
2021
Q3 | $341K | Buy |
+1,205
| New | +$341K | 0.01% | 857 |
|
2020
Q4 | – | Sell |
-4,651
| Closed | -$1.32M | – | 986 |
|
2020
Q3 | $1.32M | Buy |
4,651
+159
| +4% | +$45.1K | 0.05% | 315 |
|
2020
Q2 | $1.2M | Buy |
4,492
+276
| +7% | +$73.9K | 0.05% | 315 |
|
2020
Q1 | $1.33M | Sell |
4,216
-441
| -9% | -$140K | 0.06% | 257 |
|
2019
Q4 | $1.38M | Sell |
4,657
-209
| -4% | -$62K | 0.05% | 300 |
|
2019
Q3 | $1.08M | Buy |
+4,866
| New | +$1.08M | 0.05% | 329 |
|
2019
Q1 | – | Sell |
-790
| Closed | -$238 | – | 671 |
|
2018
Q4 | $238 | Sell |
790
-109
| -12% | -$33 | 0.02% | 545 |
|
2018
Q3 | $318K | Sell |
899
-485
| -35% | -$172K | 0.02% | 476 |
|
2018
Q2 | $409 | Sell |
1,384
-55
| -4% | -$16 | 0.04% | 342 |
|
2018
Q1 | $384K | Buy |
+1,439
| New | +$384K | 0.04% | 308 |
|
2017
Q3 | – | Sell |
-531
| Closed | -$145K | – | 440 |
|
2017
Q2 | $145K | Buy |
+531
| New | +$145K | 0.03% | 360 |
|